For IPO Boutique Research, Ratings and Commentary on all traditional IPO offerings (not direct listings), try us out: http://www.ipoboutique.com/blog/register/
IPO Boutique: Indicate with Confidence.
Debuting Tuesday (9/29)
Boqii Holding Limited (BQ) — They are the largest pet-focused platform in China, in terms of revenue in 2019 and number of customers as of December 31, 2019, according to Frost & Sullivan.
Orphazyme A/S (ORPH) — They are a late-stage biopharmaceutical company harnessing the amplification of Heat Shock Proteins, or HSPs, in order to develop and commercialize novel therapeutics for the treatment of neurodegenerative orphan diseases.
Debuting Wednesday (9/30)
Chindata Group Holdings Limited (CD) — They are the leading carrier-neutral hyperscale data center solution provider in Asia-Pacific emerging markets, focusing on the China, India and Southeast Asia markets.
Lixiang Education Holding Co., Ltd. (LXEH) — They are a prominent private primary and secondary education service provider in Lishui City, Zhejiang Province.
Yalla Group Limited (YALA) — They are the largest voice-centric social networking and entertainment platform in MENA (Middle East & North Africa) as measured by revenue in 2019, according to the Frost & Sullivan Report.
Debuting Thursday (10/1)
Mission Produce, Inc. (AVO) — They are a world leader in sourcing, producing and distributing fresh avocados, serving retail, wholesale and foodservice customers in over 25 countries.
Pulmonx Corporation (LUNG) — They are a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD).
Debuting Friday (10/2)
Academy Sports and Outdoors, Inc. (ASO) — They are one of the leading full-line sporting goods and outdoor recreation retailers in the United States.
C4 Therapeutics Inc (CCCC) —They are a biopharmaceutical company focused on harnessing the body’s natural regulation of protein levels to develop novel therapeutic candidates to target and destroy disease-causing proteins for the treatment of cancer, neurodegenerative conditions and other diseases.
Immunome Inc. (INMN) — They are a biopharmaceutical company utilizing their proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated.
Oncorus, Inc (ONCS) — They are a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies to transform outcomes for cancer patients.
In addition, there are two companies debuting via a direct listing. Palantir Technologies (PLTR) & Asana Inc (ASAN) are both tentatively scheduled to debut on 9/30. Because these companies are going public through the direct listing route, we will not be providing coverage on their company leading up to the debut.
For IPO Boutique Research, Ratings and Commentary on all traditional IPO offerings (not direct listings), try us out: http://www.ipoboutique.com/blog/register/
IPO Boutique: Indicate with Confidence.
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish